Pfizer and BioNTech say U.S. government has purchased additional 50 million pediatric doses of their COVID vaccineMarket Watch • 10/28/21
Pfizer and BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future NeedsBusiness Wire • 10/28/21
2 Top Dividend Stocks That Can Safeguard Your Portfolio Against a Market CrashThe Motley Fool • 10/27/21
FDA's Adcomm Almost Unanimously Back Pfizer/BioNTech's COVID-19 Shots For Younger KidsBenzinga • 10/27/21
The FDA's expert panel just gave a thumbs-up for Pfizer's COVID-19 vaccine in younger children, clearing the path for authorization in a matter of daysBusiness Insider • 10/26/21
FDA Advisory Committee Recommends Authorizing Pfizer's Covid Vaccine For Kids Ages 5 To 11Forbes • 10/26/21
Why Pfizer and BioNTech Will Be Bigger Winners Than Moderna With Mix-and-Match BoostersThe Motley Fool • 10/26/21
The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years oldBusiness Insider • 10/25/21
Big Tech earnings, Pfizer COVID-19 booster shot meeting, inflation data top week aheadFox Business • 10/24/21
Covid vaccine boosters are now available. Here's who's eligible for Pfizer, Moderna and J&J's shotsCNBC • 10/23/21